| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.11 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.098 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.096 | 0.09 |